成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 108409-83-2 Chemical Structure| 108409-83-2

Structure of FH535
CAS No.: 108409-83-2

Chemical Structure| 108409-83-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 108409-83-2

,{[proInfo.pro_purity]}

FH535 is an inhibitor of Wnt/β-catenin and PPAR with antitumor activities.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of FH535

CAS No. :108409-83-2
Formula : C13H10Cl2N2O4S
M.W : 361.20
SMILES Code : O=S(C1=CC(Cl)=CC=C1Cl)(NC2=CC=C([N+]([O-])=O)C=C2C)=O
MDL No. :MFCD01212888
InChI Key :AXNUEXXEQGQWPA-UHFFFAOYSA-N
Pubchem ID :3463933

Safety of FH535

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H318
Precautionary Statements:P264-P270-P280-P301+P312-P305+P351+P338-P310-P330-P501
Class:8
UN#:1759
Packing Group:

Isoform Comparison

Biological Activity

Target
  • PPARγ

In Vitro:

Cell Line
Concentration Treated Time Description References
ARPE-19 cells 0.5 μM 48 h To assess the impact of FH535 on the activation of EMT; FH535 treatment significantly attenuated the increase of EMT-related markers in TGFβ1-treated ARPE-19 cells. PMC10967154
Transformed human hepatocytes (THH) 5 μM 48 h The combination of AZD5363 and FH535 treatment displays a much greater (~80%) cell death. PMC7367822
KYSE-150R cells 20 μM 24 hours FH535 reduced the expression of nuclear β-catenin, reversed EMT phenotypes, and increased the radiosensitivity of KYSE-150R cells. PMC4384308
HTR-8/SVneo cells 30 mM 72 hours To investigate the effect of FH535 on glucose uptake and apoptosis in HTR-8/SVneo cells under high glucose conditions. The results showed that FH535 treatment reversed the glucose uptake dysfunction and apoptosis induced by high glucose. PMC10463356
Caco2 cells 20μM 2 hours To verify the protective effect of BBR on TNF-α induced TJ damage in Caco2 cells PMC8898376

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice laser-induced CNV model Intravitreal injection 0.5 μmol/L single treatment To evaluate the effect of FH535 on subretinal fibrosis; the area of transformed RPE was reduced by 52.57%. PMC10967154

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.84mL

2.77mL

1.38mL

27.69mL

5.54mL

2.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories